Programmed death-ligand 1 (PD-L1) expression in pheochromocytoma.

Authors

null

Yasuhiro Hashimoto

Hirosaki University Graduate School of Medicine, Hirosaki, Japan

Yasuhiro Hashimoto , Hayato Yamamoto , Shingo Hatakeyama , Takahiro Yoneyama , Chikara Ohyama

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Adrenal Cancer

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 537)

DOI

10.1200/JCO.2019.37.7_suppl.537

Abstract #

537

Poster Bd #

N2

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Genitourinary Cancers Symposium

Expression of Nectin-4 and PD-L1 in bladder cancer with variant histology.

Expression of Nectin-4 and PD-L1 in bladder cancer with variant histology.

First Author: Katherine Case

Poster

2019 Genitourinary Cancers Symposium

Immunogenomic landscape of neuroendocrine small cell prostate cancer.

Immunogenomic landscape of neuroendocrine small cell prostate cancer.

First Author: Lucia Nappi

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Microsatellite instability (MSI) in patients with gastric cancer (GC) and correlation with PD-L1 expression.

Microsatellite instability (MSI) in patients with gastric cancer (GC) and correlation with PD-L1 expression.

First Author: Henian Sun

Poster

2023 ASCO Annual Meeting

A comprehensive pan-cancer analysis of PD-L1 expression using clone E1L3N in Chinese patients with cancer.

A comprehensive pan-cancer analysis of PD-L1 expression using clone E1L3N in Chinese patients with cancer.

First Author: Huangbin Lu